Skip to main content
Signal8

Burns John Thomas

SEC insider (Form 3/4/5 filer). CIK 0001568734. CFO at SELLAS Life Sciences Group, Inc. (SLS). 5 reported Form 4/5 transactions since Sep 2024; latest on Jan 7, 2026. Located in NEW YORK, NY.

Companies Burns John Thomas has filed insider reports for

  • SELLAS Life Sciences Group, Inc. (SLS): Officer, CFO
Burns John Thomas profile photo

Burns John Thomas

CIK: 0001568734

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (40.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

SELLAS Life Sciences Group, Inc. logo
SLS

SELLAS Life Sciences Group, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • SELLAS Life Sciences Group, Inc. logo
    SLS

    SELLAS Life Sciences Group, Inc.

    Jan 7, 2026
    Award
    Direct
    300K shares-
  • SELLAS Life Sciences Group, Inc. logo
    SLS

    SELLAS Life Sciences Group, Inc.

    Dec 3, 2025
    Other
    Direct
    58.6K shares at avg. $1.50$88K
  • SELLAS Life Sciences Group, Inc. logo
    SLS

    SELLAS Life Sciences Group, Inc.

    Jan 10, 2025
    Award
    Direct
    113K shares-
  • SELLAS Life Sciences Group, Inc. logo
    SLS

    SELLAS Life Sciences Group, Inc.

    Jan 10, 2025
    Award
    Direct
    81.3K shares-
  • SELLAS Life Sciences Group, Inc. logo
    SLS

    SELLAS Life Sciences Group, Inc.

    Dec 4, 2024
    Other
    Direct
    7.2K shares at avg. $1.13$8K

1-5 of 5